After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

Multiple chemicals in cigarette smoke and e-cigarettes alter the function of a key type of lung immune cell. Cigarette ...

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

In their study, the researchers looked at the effects of cigarette smoke on Mucosal-Associated Invariant T (MAIT) cells, a ...

Cigarette smoking is widespread and deadly, yet our understanding of how cigarette smoke actually causes serious respiratory ...

New Study Shows Promising Results for COPD Treatment Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave ...

Study identifies NMLR as a predictor of 5-year mortality in COPD patients, paving the way for personalised care and improved survival outcomes.

State health officials are urging New Yorkers to take preventative measures against a virus that's similar to RSV.